The establishment of a methadone treatment clinic for women in Tehran, Iran

Journal of Public Health Policy

Volumn 32, Issue 2, 2011, Pages 219-230

  Dolan, Kate ^a   Salimi, Shabnam ^b   Nassirimanesh, Bijan ^c   Mohsenifar, Setareh ^b   Mokri, Azarakhsh ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Persepolis Centre   (Iran)

Author keywords

HIV; Iran; methadone; women drug users

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; FEMALE; HARM REDUCTION; HEALTH SERVICE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAN; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANALGESICS, OPIOID; FEMALE; HARM REDUCTION; HEPATITIS C; HIV INFECTIONS; HUMANS; IRAN; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; SUBSTANCE-RELATED DISORDERS; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES; YOUNG ADULT;

EID: 79954487433     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.1057/jphp.2011.10     Document Type: Article

References (22)

1. United Nations Office on Drugs and Crime. (2009) Afghanistan Opium Survey, United Nations, Vienna, 1 September. http://www.unodc.org/documents/ crop-monitoring/Afghanistan/Afghanistan-opium-survey-2009-summary.pdf, accessed June 2010.
2. United Nations Office on Drugs and Crime. (2006) World Drug Report 2006, http://www.unodc.org/unodc/en/data-and-analysis/WDR-2006.html, accessed February 2011.
3. Mokri, A. (2002) Brief overview of the status of drug abuse in Iran, http://www.ams.ac.ir/aim/0253/0253184.htm, accessed January 2011.
4. Gouya, M. M. (2005) National Report on HIV and AIDS Cases. Tehran: Disease Management Center, Ministry of Health and Medical Education, Islamic Republic of Iran.
5. Razani, N. et al (2007) HIV risk behavior among injection drug users in Tehran, Iran. Addiction 102(9):1472-1482. (Pubitemid 47246990)
6. Dolan, K., Kite, B., Black, E., Aceijas, C. and Stimson, G. V. (2007) HIV in prison in low-income and middle-income countries. Lancet Infectious Diseases 7(1):32-41. (Pubitemid 44940759)
7. Kim, W. (2002) Global epidemiology and burden of hepatitis C. Microbes and Infection 4(12):1219-1225. (Pubitemid 35435276)
8. Rahbar, A. R., Rooholamini, S. and Khoshnood, K. (2004) Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. International Journal of Drug Policy 15:151-155. (Pubitemid 38373954)
9. Grella, E. G., Scotty, C. K. and Foss, M. (2005) Gender differences in long-term treatment outcomes in Chicago PETS. Journal of Substance Abuse Treatment 28 (Suppl 1): S3-12. (Pubitemid 40387916)
10. Vazirian, M. et al (2005) Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study. Harm Reduction Journal 2:19.
11. Razzaghi, E., Nassirimanesh, B., Afshar, P., Ohiri, K., Claeson, M. and Power, R. (2006) HIV/AIDS harm reduction in Iran. The Lancet 5; 368(9534):434-435. (Pubitemid 44142754)
12. Day, C., Nassirimanesh, B., Shakeshaft, A. and Dolan, K. (2006) Patterns of drug use among a sample of drug users and injecting drug users attending a general practice in Iran. Harm Reduction Journal 3:2.
13. Pincock, S. and Dolan, K. (2008) Lunch with The Lancet. The Lancet 372(9645):1213.
14. Dolan, K., Wodak, A., Hall, W., Gaughwin, M. and Rae, F. (1996) HIV risk behaviour of IDUs before, during and after imprisonment in New South Wales. Addiction Research 4(2):151-160. (Pubitemid 126464291)
15. Day, C., Ross, J. and Dolan, K. (2003) Hepatitis C related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination? Drug and Alcohol Review 22(3):317-321. (Pubitemid 37394839)
16. Pinkham, S. and Malinowska-Sempruch, K. (2008) Women, harm reduction and HIV. Reproductive Health Matters 16(31):168-181. (Pubitemid 351718531)
17. Post, J. J., Dolan, K., Whybin, L. R., Carter, I. W. J., Haber, P. S. and Lloyd, A. R. (2001) Acute hepatitis C virus infection in an Australian prison inmate: Tattooing as a possible transmission route. Medical Journal of Australia 174(4):183-184. (Pubitemid 32166338)
18. Dolan, K., Hall, W., Wodak, A. and Gaughwin, M. (1994) Evidence of HIV transmission in an Australian prison. Medical Journal of Australia 6; 160(11):734. (Pubitemid 24166798)
19. Dolan, K. and Wodak, A. (1996) An international review of methadone provision in prisons. Addiction Research 4(1):85-97.
20. Dolan, K., Wodak, A. and Hall, W. (1998) Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug and Alcohol Review 17(2):153-158.
21. Dolan, K., Mattick, R. P., Shearer, J., MacDonald, M., Hall, W. and Wodak, A. (2003) A randomized controlled trial of methadone maintenance treatment vs. wait list control in an Australian prison system. Drug and Alcohol Dependence 72(1):59-65. (Pubitemid 37255330)
22. Dolan, K., Shearer, J., White, B., Zhou, J. and Wodak, A. (2005) Four-year follow-up of imprisoned male heroin users and methadone treatment: Mortality, re-incarceration and hepatitis C infection. Addiction 100(6):820-828. (Pubitemid 40769826)